Professor Dr. Teh Lay Kek
UiTM Puncak Alam Campus

Professor Teh Lay Kek has spent more than two decades turning genomic insight into practical bedside tools. Among Malaysia’s first PhD holders in pharmacogenetics (2000), she devised rapid PCR assays now standard for detecting HLA-B*15:02–linked SJS/TEN risk, warfarin bleeding propensity, aspirin gastritis, and resistance to clopidogrel, primaquine, antipsychotics, and tamoxifen. Her lab’s innovations span sport-genomics, nutrigenetics, and allergy panels—earning three patents, a trademark, and multiple innovation awards. In 2013 she published the first whole-genome sequence of a Malay individual and built the genotype-phenotype database that anchors national precision-medicine initiatives. To speed real-world uptake, Prof Teh co-founded Zakesy Biotech, commercialising personal genome analysis and pharmacogenotyping in collaboration with hospitals and industry partners—work that recently pinpointed causal mutations for Danon Disease and CADASIL, enabling tailored therapy. Chairing the Developing Countries division of the Pharmacogenomics Global Research Network and presiding over the Malaysian Metabolomics Society, she has secured RM 1.9 million in grants, mentored 25 postgraduates, and authored 127 peer-reviewed papers (h-index 25). A sought-after speaker, Professor Teh champions “omics-driven” healthcare as the foundation for safer, more precise treatment nationwide.

Dr. Chin Sek Peng
Department of Pharmaceutical Chemistry
Faculty of Pharmacy, Universiti Malaya

Dr. Chin Sek Peng is a Senior Lecturer in the Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Universiti Malaya (UM). She holds a Ph.D. in Drug Discovery and a B.Sc. (Hons) in Bioinformatics from UM, as well as an M.Sc. in Pharmacy from Universiti Sains Malaysia (USM). Her research focuses on computational drug discovery, integrating computational modelling and molecular simulations to design and identify novel therapeutics. Recently, she has expanded her expertise by collaborating closely with artificial intelligence (AI) experts, incorporating AI-driven approaches to enhance drug discovery. She also works alongside chemists, cell biochemists, and molecular biologists to bridge computational predictions with experimental validation. A strong advocate of lifelong learning, she actively participates in scientific collaborations, workshops, and training programs to stay at the forefront of emerging technologies. In addition, she has taken on key academic and administrative roles at UM, contributing to postgraduate training and program coordination. Dr. Chin is committed to advancing pharmaceutical sciences through innovative research and interdisciplinary collaborations, striving to make impactful contributions to drug discovery and development.

Mr Goh Man Fye
Chief AI Officer
QMed Asia

Mr Goh Man Fye is a pharmacist‑turned‑Data Scientist who currently serves as Chief AI Officer at Qmed Asia, a top Malaysian health‑tech company focused on digital patient journeys and AI‑powered clinical tools. In parallel, he’s the founder of Wistify Sdn Bhd, the team behind Medcare Pharmacy Management, helping drive digital transformation in community pharmacies across Malaysia. Holding a Pharmacy degree and a Master’s in Data Science & Analytics, Manfye leads Qmed’s core AI initiatives in triage, medical scribing, and automated diabetic‑retinopathy eye screening, collaborating with clinics, hospitals, and academic institutions. Additionaly, he spearheads digital transformation specifically for community pharmacies across Malaysia via developing multiple pharmacy related technologies. Previously, he has built several digital solutions serving pharmacists and public health such as the My Blue Book, WhereMyMask and served as the informatics pharmacists for Cawangan Teknologi Maklumat & Informatik Farmasi (CTMIF) within the Pharmaceutical Services Division, contributing to healthcare data infrastructure.He was featured in MyYoungRx Series 4 by the MPS Young Pharmacists Chapter, where he shared his journey—from clinical pharmacy to health‑tech innovation—and discussed tools like My Blue Book and WhereMyMask. He inspired pharmacists to become “game‑changers” in Malaysia’s healthcare system. Manfye also regularly speaks at national forums on digital pharmacy transformation, AI governance, and health‑data infrastructure—bridging clinical insight with technical strategy to deliver actionable and compliant AI tools for healthcare teams and regulators across the country.

Professor Dato’ Dr. Mohd Zaki Salleh
Director
Zakesy Biotech

Professor Dato’ Dr Mohd Zaki Salleh is a pioneer of Malaysian pharmacogenomics and precision health. As Director of the Integrative Pharmacogenomics Institute (iPROMISE), Universiti Teknologi MARA, and founding Director of Zakesy Biotech Sdn Bhd, he spearheaded the first complete Malay‐genome project and has since led large-scale sequencing of Orang Asli populations, rare-disease cohorts, and priority pathogens including SARS-CoV-2. His team pairs multi-omics datasets with AI-driven analytics to deliver clinically actionable pharmacogenomic reports now commercialised through Zakesy Biotech. With more than 130 publications and over 3,700 citations, Prof Zaki is a researcher who translates cutting-edge research into real-world precision-medicine services, showing how data science and genomics can transform pharmacy practice across Malaysia and beyond.